Real-world efficacy of ramucirumab plus paclitaxel with or without nivolumab in advanced gastric and gastroesophageal junction cancers. Annals of Medical Research, [S. l.], v. 33, n. 3, p. 091–098, 2026. Disponível em: http://www.annalsmedres.org/index.php/aomr/article/view/4905. Acesso em: 30 mar. 2026.